Physician profile
Robert B Hodges
NPI 1568577948
$1,021.73
in general payments reported to CMS, 2019-2025
20 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $109 · 2021: $159 · 2022: $155 · 2023: $118 · 2024: $206 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $141.63 | 2022-2025 | Rocklatan |
| Sun Pharmaceutical Industries INC. | $137.46 | 2019-2021 | |
| Abbvie INC. | $130.94 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $107.24 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $66.92 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $48.98 | 2022-2023 | Acthar |
| Thea Pharma INC. | $43.53 | 2024-2025 | Iyuzeh |
| Kala Pharmaceuticals, INC. | $40.68 | 2021 | |
| Bausch & Lomb Americas INC. | $38.44 | 2022-2025 | Miebo |
| Omeros Corporation | $36.64 | 2019-2021 | |
| Oyster Point Pharma, INC. | $34.65 | 2022-2023 | Tyrvaya |
| Rxsight INC | $32.89 | 2021 | |
| Aerie Pharmaceuticals, INC. | $31.85 | 2019 | |
| Amgen INC. | $28.79 | 2024 | Tepezza |
| Apellis Pharmaceuticals, INC. | $20.34 | 2025 | Syfovre |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $20.09 | 2020 | |
| Sight Sciences, INC. | $19.25 | 2022 | |
| Horizon Therapeutics Plc | $16.23 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.13 | 2020 | |
| Allergan, INC. | $12.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hodges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.